Efficacy and safety of the glucagon-like peptide-1 receptor agonist oral semaglutide in patients with type 2 diabetes mellitus: aA systematic review and meta-analysis - Li, J; He, K; Ge, J (Diabetes Res Clin Pract, 2021)
et al.